Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Shu Yuasa"'
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background We collaborated with the regional pharmaceutical associations near Nagoya Memorial Hospital and created a communication sheet for pharmaceutical cooperation between the hospital and health insurance pharmacies. Methods The communi
Externí odkaz:
https://doaj.org/article/7b0205f0ce8e4c66b7a8e7e757e0f2c6
Autor:
Satoshi Hibi, Kenji Ina, Shu Yuasa, Nobuto Ito, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Takashi Yoshida, Satoshi Kayukawa
Publikováno v:
Journal of Cancer Research Updates. 11:78-82
The reactivation of the hepatitis B virus (HBV) following systemic chemotherapy reportedly caused acute liver dysfunction as a fatal complication. HBV reactivation sometimes occurs even after the cessation of chemotherapy, especially in the patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce930003b5c43bf9bca876ac3fd4e20e
https://doi.org/10.30683/1929-2279.2022.11.11
https://doi.org/10.30683/1929-2279.2022.11.11
Autor:
Shu Yuasa, Megumi Kabeya, Satoshi Hibi, Yuko Shirokawa, Chiaki Tokoro, Ryuichi Furuta, Seiji Nagao, Satoshi Kayukawa, Yoshiteru Tanaka, Kenji Ina
Publikováno v:
Journal of Analytical Oncology. 11:40-44
Epidermal growth factor receptor (EGFR) has received significant attention for its therapeutic potential for pain relief. The relief of neuropathic pain after treatment with anti-EGFR antibodies or tyrosine kinase inhibitors has been previously descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fa7c24e02ccc4f4b664043b042f5ba6
https://doi.org/10.30683/1927-7229.2022.11.06
https://doi.org/10.30683/1927-7229.2022.11.06
Autor:
Satoshi Hibi, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Nobuto Ito, Takae Kataoka, Takashi Yoshida, Yoshiaki Marumo, Satoshi Kayukawa, Shu Yuasa, Yoshiteru Tanaka, Kenji Ina
Publikováno v:
Journal of Analytical Oncology. 10:61-68
Background: Immune checkpoint inhibitors (ICIs) sometimes cause immune-related adverse events (irAEs), the timing of occurrence of which is difficult to predict. We created a system to safely manage the patients treated with ICIs who visit hospital d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f72a51cb68594680fcf178a79d1bccc
https://doi.org/10.30683/1927-7229.2021.10.06
https://doi.org/10.30683/1927-7229.2021.10.06
Background Delirium -characterized by an acute or subacute decline in cognitive functioning- and confusion are risk factors for falls and its related injuries. Therefore, we designed a unified clinical pathway to reduce the risk of delirium among hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b59d0b6a58f6a411ef77dbc34267fc0
https://doi.org/10.21203/rs.3.rs-955231/v1
https://doi.org/10.21203/rs.3.rs-955231/v1
Autor:
Satoshi Hibi, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Nobuto Ito, Takae Kataoka, Takashi Yoshida, Yoshiaki Marumo, Satoshi Kayukawa, Shu Yuasa, Kenji Ina
BackgroundImmune checkpoint inhibitors (ICIs) sometimes cause immune-related adverse events (irAEs), the timing of occurrence of which is difficult to predict. We created a system to safely manage the patients treated with ICIs who visit hospital dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6effe4b0f7319953e701130d535c848a
https://doi.org/10.21203/rs.3.rs-970795/v1
https://doi.org/10.21203/rs.3.rs-970795/v1
Autor:
Megumi Kabeya, Takae Kataoka, Shu Yuasa, Ryuichi Furuta, Satoshi Kayukawa, Kenji Ina, Yuko Kato
Publikováno v:
Journal of Cancer Therapy. 10:779-788
Backgrounds: Colorectal cancer is an important contributor to cancer morbidity and mortality. Given that many older adult patients often have concomitant diseases and impairments in organ function, they are at increased risk for chemotherapy toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::348f7f448c1c05321dee6ce82d96284e
https://doi.org/10.4236/jct.2019.1010065
https://doi.org/10.4236/jct.2019.1010065
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-10 (2020)
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-10 (2020)
Background We collaborated with the regional pharmaceutical associations near Nagoya Memorial Hospital and created a communication sheet for pharmaceutical cooperation between the hospital and health insurance pharmacies. Methods The communication sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42abed91bda6edb7871050f96ea94ee
https://pubmed.ncbi.nlm.nih.gov/33042565
https://pubmed.ncbi.nlm.nih.gov/33042565
Autor:
Takae Kataoka, Nobuto Ito, Satoshi Hibi, Yuko Shirokawa, Satoshi Kayukawa, Shu Yuasa, Kenji Ina, Yuko Kato, Kengo Nanya, Ryuichi Furuta, Takashi Yoshida, Naohiro Matsunaga, Yoshiaki Marumo, Megumi Kabeya
Publikováno v:
Annals of Oncology. 32:S351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa3304d34e3f9a3d1e84305b8dc01fe3
https://doi.org/10.1016/j.annonc.2021.05.754
https://doi.org/10.1016/j.annonc.2021.05.754
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 41:275-282
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b2875938ee6b8a23fc23e126806b800
https://doi.org/10.5649/jjphcs.41.275
https://doi.org/10.5649/jjphcs.41.275